Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?
A list of top biotech penny stocks includes Inozyme Pharma, Inc. (NASDAQ:INZY) showing promise in rare disease therapeutics. Analysts rate it a Strong Buy with potential for significant growth.